Filing Flows › Lucid Diagnostics (LUCD) › Q1 2026 › vs Q1 2025
Lucid Diagnostics (LUCD) Q1 2026 vs Q1 2025 (year over year)
Lucid Diagnostics's revenue rose $428K (+52%) from $828K in Q1 2025 to $1.3M in Q1 2026.
Lucid Diagnostics, Q1 2026: revenue $1.3M (+52% year over year), operating margin -964.5%, net loss $13.9M, operating cash flow −$12.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.3M | $828K | $428K | +52% |
| Net loss | $13.9M | $26.9M | −$13.0M | -48% |
| Costs & expenses | $15.2M | $27.7M | −$12.6M | -45% |
| Operating costs | $13.4M | $13.3M | $55K | +0.4% |
| Interest & other, net | $1.8M | $14.4M | −$12.6M | -88% |
| Cost of revenue | $1.6M | $1.6M | $74K | +5% |
| Research & development | $1.2M | $1.4M | −$222K | -16% |
| Sales & marketing | $5.0M | $4.1M | $933K | +23% |
| General & admin | $5.4M | $6.2M | −$730K | -12% |
| Other operating costs | $105K | $105K | $0 | 0% |
| Operating cash sources | $13.9M | $26.9M | −$13.0M | -48% |
| Depreciation & amortization | $222K | $221K | $1K | +0.5% |
| Share-based compensation | $1.4M | $949K | $462K | +49% |
| Working capital & other | $175K | $13.3M | −$13.1M | -99% |
| Cash used in operations | $12.1M | $12.5M | −$364K | -3% |
| Net loss absorbed | $13.9M | $26.9M | −$13.0M | -48% |
Questions
How much did Lucid Diagnostics's revenue grow year over year in Q1 2026?
Lucid Diagnostics's revenue rose $428K (+52%) from $828K in Q1 2025 to $1.3M in Q1 2026.